Advocacy intelligence hub — real-time data for patient organizations
Qilu Pharmaceutical Co., Ltd. — PHASE3
Assistance Publique - Hôpitaux de Paris — NA
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. — PHASE3
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine — EARLY_PHASE1
Nantes University Hospital — NA
LIB Therapeutics LLC — PHASE3
Merck Sharp & Dohme LLC — PHASE2, PHASE3
Novartis Pharmaceuticals
Children's Hospital of Fudan University
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs